• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用多变量磁共振成像形态测量、稀疏编码和核相关熵预测大脑皮质中的tau蛋白积累

Predicting Tau Accumulation in Cerebral Cortex with Multivariate MRI Morphometry Measurements, Sparse Coding, and Correntropy.

作者信息

Wu Jianfeng, Zhu Wenhui, Su Yi, Gui Jie, Lepore Natasha, Reiman Eric M, Caselli Richard J, Thompson Paul M, Chen Kewei, Wang Yalin

机构信息

School of Computing, Informatics, and Decision Systems Engineering, Arizona State University, Tempe, USA.

Banner Alzheimer's Institute, Phoenix, USA.

出版信息

Proc SPIE Int Soc Opt Eng. 2021 Nov;12088. doi: 10.1117/12.2607169. Epub 2021 Dec 10.

DOI:10.1117/12.2607169
PMID:34961803
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8710175/
Abstract

Biomarker-assisted diagnosis and intervention in Alzheimer's disease (AD) may be the key to prevention breakthroughs. One of the hallmarks of AD is the accumulation of tau plaques in the human brain. However, current methods to detect tau pathology are either invasive (lumbar puncture) or quite costly and not widely available (Tau PET). In our previous work, structural MRI-based hippocampal multivariate morphometry statistics (MMS) showed superior performance as an effective neurodegenerative biomarker for preclinical AD and Patch Analysis-based Surface Correntropy-induced Sparse coding and max-pooling (PASCS-MP) has excellent ability to generate low-dimensional representations with strong statistical power for brain amyloid prediction. In this work, we apply this framework together with ridge regression models to predict Tau deposition in Braak12 and Braak34 brain regions separately. We evaluate our framework on 925 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Each subject has one pair consisting of a PET image and MRI scan which were collected at about the same times. Experimental results suggest that the representations from our MMS and PASCS-MP have stronger predictive power and their predicted Braak12 and Braak34 are closer to the real values compared to the measures derived from other approaches such as hippocampal surface area and volume, and shape morphometry features based on spherical harmonics (SPHARM).

摘要

生物标志物辅助诊断及干预阿尔茨海默病(AD)可能是预防取得突破的关键。AD的标志性特征之一是人脑中tau蛋白斑块的积累。然而,目前检测tau蛋白病理的方法要么具有侵入性(腰椎穿刺),要么成本高昂且无法广泛应用(tau蛋白正电子发射断层扫描)。在我们之前的工作中,基于结构磁共振成像的海马多变量形态测量统计(MMS)作为临床前AD的有效神经退行性生物标志物表现出卓越性能,且基于补丁分析的表面相关熵诱导稀疏编码和最大池化(PASCS-MP)具有出色的能力,能够生成具有强大统计能力的低维表示用于脑淀粉样蛋白预测。在这项工作中,我们将此框架与岭回归模型一起应用,分别预测Braak12和Braak34脑区的tau蛋白沉积。我们在来自阿尔茨海默病神经成像倡议(ADNI)的925名受试者上评估我们的框架。每个受试者都有一对大约在同一时间采集的PET图像和MRI扫描图像。实验结果表明,与从其他方法(如海马表面积和体积以及基于球谐函数(SPHARM)的形状形态测量特征)得出的测量值相比,我们的MMS和PASCS-MP生成的表示具有更强的预测能力,并且它们预测的Braak12和Braak34更接近真实值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c6/8710175/2a6860cffe8e/nihms-1749983-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c6/8710175/966119a226d7/nihms-1749983-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c6/8710175/d7354b76eea5/nihms-1749983-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c6/8710175/78a0188ce891/nihms-1749983-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c6/8710175/db5b403cb085/nihms-1749983-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c6/8710175/2a6860cffe8e/nihms-1749983-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c6/8710175/966119a226d7/nihms-1749983-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c6/8710175/d7354b76eea5/nihms-1749983-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c6/8710175/78a0188ce891/nihms-1749983-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c6/8710175/db5b403cb085/nihms-1749983-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c6/8710175/2a6860cffe8e/nihms-1749983-f0005.jpg

相似文献

1
Predicting Tau Accumulation in Cerebral Cortex with Multivariate MRI Morphometry Measurements, Sparse Coding, and Correntropy.利用多变量磁共振成像形态测量、稀疏编码和核相关熵预测大脑皮质中的tau蛋白积累
Proc SPIE Int Soc Opt Eng. 2021 Nov;12088. doi: 10.1117/12.2607169. Epub 2021 Dec 10.
2
Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding.利用海马表面多变量形态计量统计学和稀疏编码提高淀粉样蛋白-β和 Tau 负荷的预测能力。
J Alzheimers Dis. 2023;91(2):637-651. doi: 10.3233/JAD-220812.
3
Predicting Brain Amyloid Using Multivariate Morphometry Statistics, Sparse Coding, and Correntropy: Validation in 1,101 Individuals From the ADNI and OASIS Databases.使用多变量形态测量统计、稀疏编码和核熵估计预测脑淀粉样蛋白:在来自阿尔茨海默病神经影像倡议(ADNI)和老年脑成像数据集(OASIS)数据库的1101名个体中的验证
Front Neurosci. 2021 Aug 6;15:669595. doi: 10.3389/fnins.2021.669595. eCollection 2021.
4
HIPPOCAMPUS MORPHOMETRY STUDY ON PATHOLOGY-CONFIRMED ALZHEIMER'S DISEASE PATIENTS WITH SURFACE MULTIVARIATE MORPHOMETRY STATISTICS.采用表面多变量形态计量学统计方法对经病理证实的阿尔茨海默病患者进行海马形态计量学研究。
Proc IEEE Int Symp Biomed Imaging. 2018 Apr;2018:1555-1559. doi: 10.1109/ISBI.2018.8363870. Epub 2018 May 24.
5
Federated Morphometry Feature Selection for Hippocampal Morphometry Associated Beta-Amyloid and Tau Pathology.用于海马形态测量相关β-淀粉样蛋白和tau病理学的联合形态测量特征选择
Front Neurosci. 2021 Nov 25;15:762458. doi: 10.3389/fnins.2021.762458. eCollection 2021.
6
Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding.利用表面多变量形态计量统计学和稀疏编码提高对临床显著记忆减退进展的预测能力。
J Alzheimers Dis. 2021;81(1):209-220. doi: 10.3233/JAD-200821.
7
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化:两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
8
Combining Blood-Based Biomarkers and Structural MRI Measurements to Distinguish Persons with and without Significant Amyloid Plaques.将基于血液的生物标志物与结构 MRI 测量结果相结合,以区分有和无大量淀粉样斑块的个体。
J Alzheimers Dis. 2024;98(4):1415-1426. doi: 10.3233/JAD-231162.
9
ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.载脂蛋白E4对轻度认知障碍和阿尔茨海默病自动诊断分类器的影响。
Neuroimage Clin. 2014 Jan 4;4:461-72. doi: 10.1016/j.nicl.2013.12.012. eCollection 2014.
10
Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau.基于生物标志物的 MCI 进展预测:AD 特征和海马体积与脑脊液淀粉样蛋白-β和 tau 的比较。
Front Aging Neurosci. 2013 Oct 11;5:55. doi: 10.3389/fnagi.2013.00055. eCollection 2013.

引用本文的文献

1
Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding.利用海马表面多变量形态计量统计学和稀疏编码提高淀粉样蛋白-β和 Tau 负荷的预测能力。
J Alzheimers Dis. 2023;91(2):637-651. doi: 10.3233/JAD-220812.

本文引用的文献

1
Predicting Brain Amyloid Using Multivariate Morphometry Statistics, Sparse Coding, and Correntropy: Validation in 1,101 Individuals From the ADNI and OASIS Databases.使用多变量形态测量统计、稀疏编码和核熵估计预测脑淀粉样蛋白:在来自阿尔茨海默病神经影像倡议(ADNI)和老年脑成像数据集(OASIS)数据库的1101名个体中的验证
Front Neurosci. 2021 Aug 6;15:669595. doi: 10.3389/fnins.2021.669595. eCollection 2021.
2
The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography.正电子发射断层扫描评估阿尔茨海默病中内侧颞叶tau 病的皮质起源和初始扩散。
Sci Transl Med. 2021 Jan 20;13(577). doi: 10.1126/scitranslmed.abc0655.
3
Comparing progression biomarkers in clinical trials of early Alzheimer's disease.
比较早期阿尔茨海默病临床试验中的进展生物标志物。
Ann Clin Transl Neurol. 2020 Sep;7(9):1661-1673. doi: 10.1002/acn3.51158. Epub 2020 Aug 11.
4
Longitudinal trajectory of Amyloid-related hippocampal subfield atrophy in nondemented elderly.非痴呆老年人中与淀粉样蛋白相关的海马亚区萎缩的纵向轨迹。
Hum Brain Mapp. 2020 Jun 1;41(8):2037-2047. doi: 10.1002/hbm.24928. Epub 2020 Jan 14.
5
Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET.阿尔茨海默病的前瞻性纵向萎缩与基线 tau-PET 的强度和分布相关。
Sci Transl Med. 2020 Jan 1;12(524). doi: 10.1126/scitranslmed.aau5732.
6
Applying surface-based hippocampal morphometry to study APOE-E4 allele dose effects in cognitively unimpaired subjects.应用基于表面的海马形态计量学研究认知正常的 APOE-E4 等位基因剂量效应。
Neuroimage Clin. 2019;22:101744. doi: 10.1016/j.nicl.2019.101744. Epub 2019 Mar 4.
7
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.tau PET 于常染色体显性阿尔茨海默病:与认知、痴呆和其他生物标志物的关系。
Brain. 2019 Apr 1;142(4):1063-1076. doi: 10.1093/brain/awz019.
8
Morphological changes in subregions of hippocampus and amygdala in major depressive disorder patients.重度抑郁症患者海马体和杏仁核亚区的形态变化。
Brain Imaging Behav. 2020 Jun;14(3):653-667. doi: 10.1007/s11682-018-0003-1.
9
HIPPOCAMPUS MORPHOMETRY STUDY ON PATHOLOGY-CONFIRMED ALZHEIMER'S DISEASE PATIENTS WITH SURFACE MULTIVARIATE MORPHOMETRY STATISTICS.采用表面多变量形态计量学统计方法对经病理证实的阿尔茨海默病患者进行海马形态计量学研究。
Proc IEEE Int Symp Biomed Imaging. 2018 Apr;2018:1555-1559. doi: 10.1109/ISBI.2018.8363870. Epub 2018 May 24.
10
Considerations and code for partial volume correcting [F]-AV-1451 tau PET data.[F]-AV-1451 tau正电子发射断层扫描(PET)数据部分容积校正的注意事项及代码
Data Brief. 2017 Oct 16;15:648-657. doi: 10.1016/j.dib.2017.10.024. eCollection 2017 Dec.